Skyrizi
Skyrizi
Skyrizi is the first treatment for Crohn’s that works differently by specifically targeting the interleukin-23 (IL-23) protein, which is one of the key proteins responsible for inflammation. Skyrizi also treats moderately to severely active rheumatoid arthritis (RA) and active psoriatic arthritis.
By targeting IL-23, SKYRIZI can help reduce the excess inflammation that may contribute to Crohn’s symptoms. It is used in adult patients to lessen the symptoms of moderately to severely active Crohn’s disease (CD) in patients who have tried and failed the usual treatments.
Administration Information
Potential Side Effects
Helpful Resources
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read